Atlas Trials

The Effect of 21-Days Intranasal Oxytocin on Patients With Post Traumatic Stress Disorder (PTSD)

Clinical trial NCT02336568 · UNKNOWN

Trial details

NCT number
NCT02336568
Sponsor
Rambam Health Care Campus
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
PTSD
Start date
2015-03-01
Primary completion
2016-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.